KBC Securities advice for Teva Pharmaceuticals
| Date | Bank | Stock | Advice | Price | Difference |
|---|---|---|---|---|---|
| February 13, 2017 | KBC Securities | Teva Pharmaceuticals | Hold | 38.00 USD | -17378.95 % |
Advice details
Brussel - Op 13 Feb 2017 (her)starten de analisten van KBC Securities met het volgen van the American pharmaceutical company Teva Pharmaceuticals (ISIN: US8816242098 / Mnemo: TEVA) met een houdadvies. Het 12-maands koersdoel is vastgesteld op 38.0 USD
Back
| About us | Network | Partners |
| Fpgroup.nlinfo@analist.nlRSS feedContactIntellectual Property Photos |
Analist.nlLinksISIN
|
MorningstarPrudena.comAAII.comNASDAQvwd GroupEuronextBATS Chi-x
|
©2025 ValueSpectrum. All Rights Reserved
Developed and maintained by 